NNMTi is a nicotinamide N-methyltransferase (NNMT) inhibitor that promotes myoblast differentiation.
CAT No: R1939
CAS No:42464-96-0
Synonyms/Alias:NNMTi;42464-96-0;5-AMINO-1-METHYLQUINOLIN-1-IUM IODIDE;5-amino-1-methylquinolinium iodide;5-Amino-1-methylquinolin-1-iumiodide;MFCD22125886;NNMTi?;5-Amino-1-mq iodide;Compound 1k, NNMT inhibitor;CHEMBL4088008;SCHEMBL21814312;AKOS015953375;1-methylquinolin-1-ium-5-amine;iodide;5-Amino-1-methyl-1-quinolinium Iodide;BS-49094;DA-56226;SY275924;HY-131042;CS-0121050;E71261;
Chemical Name:1-methylquinolin-1-ium-5-amine;iodide
4. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
5. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.